| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 136.176 | 191.596 | - | 207.938 | - | 179.918 | 189.858 | 186.892 | 468.599 | 373.012 |
| Total Income - EUR | 136.493 | 192.876 | - | 208.418 | - | 180.924 | 189.873 | 186.964 | 469.480 | 373.165 |
| Total Expenses - EUR | 139.265 | 160.784 | - | 181.944 | - | 183.993 | 134.047 | 167.014 | 328.598 | 315.704 |
| Gross Profit/Loss - EUR | -2.772 | 32.093 | - | 26.474 | - | -3.069 | 55.826 | 19.950 | 140.882 | 57.460 |
| Net Profit/Loss - EUR | -2.772 | 26.958 | - | 24.395 | - | -4.837 | 53.928 | 18.081 | 136.187 | 46.656 |
| Employees | 30 | 30 | - | 28 | - | 28 | 28 | 23 | 23 | 25 |
Check the financial reports for the company - Bioconf Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 33.928 | 31.912 | - | 23.155 | - | 428 | 24.865 | 19.810 | 37.011 | 27.797 |
| Current Assets | 87.728 | 118.211 | - | 134.755 | - | 147.734 | 129.405 | 145.535 | 202.566 | 169.394 |
| Inventories | 10.371 | 10.222 | - | 12.933 | - | 11.160 | 11.754 | 12.204 | 0 | 0 |
| Receivables | 53.874 | 66.219 | - | 22.385 | - | 51.140 | 97.272 | 100.496 | 116.324 | 103.651 |
| Cash | 23.483 | 41.769 | - | 99.438 | - | 85.434 | 20.380 | 32.835 | 86.242 | 65.743 |
| Shareholders Funds | 26.735 | 53.420 | - | 74.145 | - | 65.406 | 117.843 | 95.734 | 212.104 | 64.037 |
| Social Capital | 45 | 45 | - | 43 | - | 41 | 40 | 41 | 40 | 40 |
| Debts | 94.921 | 96.703 | - | 83.765 | - | 82.756 | 36.427 | 69.611 | 27.751 | 133.301 |
| Income in Advance | 0 | 0 | - | 0 | - | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "1410 - 1410" | |||||||||
| CAEN Financial Year |
1439
|
|||||||||
Comments - Bioconf Srl